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SUMMARY
Whole blood collected from koalas admitted to the Australian Zoo Wildlife Hospital (AZWH), Beerwah, QLd, Australia,
during late 2006–2009 was tested using trypanosome species-speciﬁc 18S rDNA PCRs designed to amplify DNA from
Trypanosoma irwini, T. gilletti and T. copemani. Clinical records for each koala sampled were reviewed and age, sex, blood
packed cell volume (PCV), body condition, signs of illness, blood loss, trauma, chlamydiosis, bone marrow disease, koala
AIDS and hospital admission outcome (‘survival’ / ‘non-survival’) were correlated with PCR results. Overall 73·8% (439/
595) of the koalas were infected with at least 1 species of trypanosome. Trypanosoma irwini was detected in 423/595 (71·1%),
T. gilletti in 128/595 (21·5%) and T. copemani in 26/595 (4·4%) of koalas. Mixed infections were detected in 125/595 (21%)
withco-infectionsofT.irwini andT.gilletti (101/595,17%)beingmostcommon.Therewasastatisticalassociationbetween
infectionwithT.gillettiwithlowerPCVvaluesandbodyconditionscoresinkoalaswithsignsofchlamydiosis,bonemarrow
disease or koala AIDS. No association between T. gilletti infection and any indicator of health was observed in koalas
without signs of concurrent disease. This raises the possibility that T. gilletti may be potentiating other disease syndromes
aﬀecting koalas.
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INTRODUCTION
Trypanosoma (Trypanosomatidae) is a diverse genus
of parasites primarily transmitted by haematopha-
gous arthropods that have been isolated from hosts
from all vertebrate classes. They are an important
group of parasites, which comprise the causative
agents of Human African trypanosomiasis (HAT)
and Chagas’ disease in humans and Nagana and
Surra in livestock and wildlife. A number of novel
trypanosome species have recently been identiﬁed in
Australian marsupials (Austen et al. 2009; McInnes
et al. 2009, 2011).
Two novel trypanosomes, T. irwini and T. gilletti
and a marsupial trypanosome known as T. copemani,
have been observed in the blood of koalas in Australia
(McInnes et al. 2009, 2011). The clinical signiﬁcance
of trypanosome infections in koalas is not clear
because the majority of infected animals are appar-
ently healthy. However, further investigation of
the impact of trypanosome infection is required
because a small number of infected koalas exhibited
clinical symptoms suggestive of trypanosomiasis
(Gillett personal communication; McInnes et al.
2009). Condition-dependent virulence has been
reported in non-pathogenic trypanosome infection
(Brown et al. 2003). Infection with T. theileri has
been associated with severe, sometimes fatal, disease
in immunosuppressed animals or in the presence of
concurrent infections (Ward et al. 1984; Doherty
et al. 1993; Seiﬁ, 1995).
The koala is currently classiﬁed as vulnerable to
extinction in New South Wales (NSW) under the
NSW Threatened Species Conservation Act 1995
No. 101 as Schedule 2 ‘Vulnerable species’ and in
part of Queensland (QLd) under the QLd Nature
Conservation (Wildlife) Regulation 2006 as Schedule
3 ‘Vulnerable wildlife’. The current vulnerable
status of koala populations is due to habitat loss and
fragmentation, hunting (fur trade, historical), urban
encroachment with increased incidents of motor
vehicle strike and dog attacks and a high prevalence
of disease.
This study was conducted to provide a better
understanding of the epidemiology of T. irwini,
T. gilletti and T. copemani in koalas, with respect to
geography as well as to host and health factors that
may be associated with severe clinical disease and
mortality.
MATERIALS AND METHODS
Sources of isolates and sample collection
Whole blood was collected from 595 koalas admitted
to the Australian Zoo Wildlife Hospital (AZWH) at
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December 2009. The majority of the koalas origi-
nated from south-east QLd or northern NSW. The
geographical origin (suburb, state), sex, age, body
condition score (0–10), reason for admission (injury,
illness, orphaned, research study, species manage-
ment or combinations thereof), blood packed
cell volume (PCV; %) and ﬁnal outcome of admission
(unassisted death, euthanasia, rehabilitation or re-
lease) were recorded. The numbers of koalas
sampled,theirstateoforigin,sexandyearofcollection
are presented in Table 1. Age was estimated from
premolar (P
4) wear according to a classiﬁcation
system devised by Martin (1981). Body condition
scores were assigned using a 10-rank scale, which is
a modiﬁcation of the 5-rank system described by
Vogelnest and Woods (2008). A rank is assigned
based on the muscle mass covering the spine of the
scapula and temporal fossa in conjunction with
the general appearance of the koala. A rank of 1 is
an extremely emaciated unhealthy koala and 10 is
a well-muscled healthy koala. Full clinical examin-
ations of koalas were conducted by veterinary staﬀ
at the AZWH, identifying clinical syndromes such
as chlamydiosis, koala acquired immune deﬁciency
syndrome (kAIDS, caused by infection with the
koala retrovirus (KoRV)) and bone marrow disease
(BMD), as well as trauma-related injuries and blood
loss (evidenced by erythrocytes in abdominal tap
and/or visible bleeding).
Koalas were anaesthetized by intramuscular
administration of 3 mg/kg of alfaxalone (Alfaxan®
CD RTU, Jurox Australia) to enable clinical ex-
amination and blood collection. Anaesthesia was
maintained with a combination of oxygen and
isoﬂurane delivered by either mask or endotracheal
intubation. Approximately 0·5–1 ml of blood was
collected by venepuncture of the cephalic vein.
The packed cell volume (PCV) was determined
by centrifugation of blood in 40 mm StatSpin micro-
haematocrit capillary tubes (Iris Sample Processing,
Westwood, MA, USA) using a StatSpin VT
(StaSpin Inc, Norwood, MA, USA). Whole blood
for DNA extraction was mixed with EDTA in a
Vacutainer® tube (Becton-Dickinson, New Jersey,
USA) and stored at −20 °C until required. Bone
marrow samples of approximately 10–20 μl were
collected from the iliac crest using an 18 gauge 1·5″
hypodermic needle (Terumo Corporation, Tokyo,
Japan) and 3 ml syringe (Becton-Dickinson Medical
(S) Pty Ltd, Singapore). A small drop of the samples
was spread brieﬂy and gently between 2 slides,
air-dried and stained using Diﬀ-Quick. Abdominal
paracentesis to obtain peritoneal ﬂuid was performed
using a 25 G×¾″ winged infusion set (Terumo
Corporation, Tokyo, Japan) and a 3ml syringe
(Becton-Dickinson Medical (S) Pty Ltd, Singapore)
inserted through the lateral abdominal wall. An air-
dried smear of peritoneal ﬂuid was prepared, ﬁxed by
immersion in methanol for 30 sec and stained with
Diﬀ-Quick (Dade Behring Diagnostics Australia Pty
Ltd, NSW, Australia). The slides were then rinsed
in tap water, air-dried and acover-slip mounted with
a drop of water. Stained slides were examined
microscopically for the presence of erythrocytes.
DNA extraction
Whole genomic DNA from each blood sample was
extracted using a MasterPure™ DNA Puriﬁcation
Kit (EPICENTRE® Biotechnologies, Madison,
Wisconsin, USA) with a modiﬁed protocol, which
allowed extraction of larger volumes of lysed whole
blood than the manufacturer’s protocol. Brieﬂy,
100 μl of whole blood was mixed with 150 μlo f2 ×
tissue lysis buﬀer (EPICENTRE® Biotechnologies)
and 50 μl of phosphate-buﬀered saline (PBS) in
labelled 1·5 ml vol. Eppendorf tubes. Tubes were
vortex-mixed and incubatedat65 °Cfor15 min,with
vortexing every 5 min. After lysis, tubes were cooled
on ice for 3–5 min before 200 μl of protein precipi-
tation agent (EPICENTRE® Biotechnologies) was
added and tubes vortexed for 15 sec. The tubes were
centrifuged at 13000 g and the supernatant trans-
ferred into new labelled tubes. Analytical grade
isopropanol (600 μl) was added to each tube and the
tubes inverted 40 times. Tubes were centrifuged at
13000 g for 10 min, supernatant discarded and the
DNA pellet washed twice with 70% analytical grade
ethanol. The resultant DNA pellet was resuspended
in 50 μl of distilled water and stored at −20°C until
use. A DNA extraction control (an empty tube
treated the same as samples processed) was included
with each batch of blood samples to ensure that batch
contamination could be identiﬁed.
Design of koala trypanosome species-speciﬁc primers
The 18S rDNA sequences of T. irwini (GenBank
FJ649479), T. gilletti (GenBank GU966589) and
T. copemani (koala) (GenBank GU966588) were
aligned using ClustalW (Thompson et al. 1994)t o
design species-speciﬁc primers in variable regions of
the 18S. The primers were designed to nest inside
primersS825(5′-ACCGTT TCGGCTTTT GTT
GG-3′) sourced from Maslov et al. (1996) and SLIR
(5′ACA TTG TAG TGC GCG TGT C-3′)f r o m
McInnes et al. (2009) which amplify a 959 bp
fragment (SS2) of Trypanosoma 18S rDNA. Try-
panosoma irwini internal primers K1F (5′-CTT
CCC TCA ACT CGT GGC TTC-3′) and K1R
(5′ -TTA ATA AAT ATT GGC GAG ACG GAG-
3′) ampliﬁed a 282 bp fragment of the 18S rDNA.
Trypanosoma gilletti internal primers K2F (5′-
TGCATCTGGTCATCATTGTATG-3′)a n dK 2 R
(5′-GGC ACC GTC TCT GCT TTA AC-3′)
ampliﬁed a 373 bp fragment of the 18S rDNA.
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GTG TTG CTT TTT TGG TCT TCA CG-3′)
and WoR (5′-CAC AAA GGA GGA AAA AAG
GGC-3′) ampliﬁed a 457 bp fragment of the 18S
rDNA.TheprimaryPCRreferredtoasSS2(primers
S825/SLIR) was conducted according to McInnes
et al. (2009). The nested species-speciﬁc PCRs were
performed using 1μl of the primary PCR amplicon
in 25 μl reactions containing 1× PCR buﬀer (with
1·5mM MgCl2), 0·1 mM dNTPs, 0·8μM of each
primer and 0·02 U/μl KapaTaq DNA polymerase
(Kapa Biosystems, Inc. Woburn, MA, USA). The
PCR conditions consisted of a pre-PCR step with
95 °C for 5 min, 50 °C for 2 min and an extension
of 72 °C for 4 min followed by 35 cycles of 94 °C for
30 sec, 56 °C for 30 sec, an extension of 72 °C for
30 sec and a ﬁnal extension of 72 °C for 7 min.
A graphical representation and an agarose gel
electrophoresis result of the PCR amplicons from
the 3 species-speciﬁc nested PCRs are presented in
Fig. 1.
The speciﬁcity of each PCR was evaluated by
DNA sequence conﬁrmation of 8–13 amplicons.
PCR products were puriﬁed using a MO BIO
UltraClean
TM 15 DNA Puriﬁcation Kit (MO BIO
Laboratories Inc. West Carlsbad, California, USA)
and sequenced using an ABI Prism
TM Terminator
Cycle Sequencing kit (Applied Biosystems, Foster
City, California, USA) on an Applied Biosystem
3730 DNA Analyzer. All samples that were nega-
tive when screened with the 18S rDNA T. irwini,
T. gilletti and T. copemani species-speciﬁc PCRs
were tested with a nested 18S rDNA PCR (SS1
consisting of primers SLF/S762 followed by primer
set S823/S662) which ampliﬁes trypanosomatid
DNA (McInnes et al. 2011).
Statistical analysis
Koalas were classiﬁed as ‘diseased’ or ‘non-diseased’
based on the presence or absence of clinical signs
of chlamydiosis, kAIDS or bone marrow disease
(BMD). The presence/absence of each trypanosome
infection was recorded and coded together with all
the other information gathered from each koala.
Koalas that were released back into the wild or placed
into care/rehabilitation were coded as ‘survival’ and
koalas that had an unassisted death or were eutha-
nased as ‘non-survival’. The statistical signiﬁcance of
any diﬀerences in continuous variables (PCV and
age) were determined using independent t-tests
(P<0·05). Packed cell volume data were excluded
for koalas that were observed to have clinical blood
loss. Statistical associations between categorical vari-
ables were determined using Pearson’s chi-square
(χ
2) or Pearson’s chi-square (χ
2) with continuity
correction or Fisher’s exact tests (P<0·05) respect-
ively. Odds ratios were calculated for signiﬁcant
associations between infections and state, sex and
outcome. The relationship between continuous vari-
ables was determined by calculating the Pearson’s
correlation coeﬃcient with a 2-sided signiﬁcance test
(P<0·05). A non-parametric Mann-Whitney U test
was used to determine the statistical signiﬁcance of
diﬀerences in the body condition scores of infected
koalas and uninfected koalas at a 95% conﬁdence
level. Statistical analyses were performed using
the Statistical Package for Social Sciences (SPSS)
17.0.1. (SPSS Inc. Chicago, IL, USA). Exact
binomial conﬁdence intervals (CI) were calculated
according to Clopper and Pearson (1934). Statistical
analyses relating to outcome in regards to signs of
kAIDS and BMD were not conducted due to the
policy of the AZWH to euthanase animals with these
syndromes.
RESULTS
A total of 439 of the 595 koalas (73·8%, CI: 70·1–
77·3%) sampled were positive when tested using the
trypanosome species-speciﬁc 18S rDNA PCRs. The
resultsfromthe3species-speciﬁcPCRsarepresented
in Table 2. All samples that were negative using
the species-speciﬁc PCR were also negative when
screened with a trypanosomatid 18S rDNA PCR. All
DNA extraction controls were PCR-negative. All
positive and negative PCR controls produced appro-
priate results. DNA sequence conﬁrmation was
carried out on the K1 (T. irwini), K2 (T. gilletti)
and Wo (T. copemani) PCR products generated from
16 koalas, 12 of which had multiple infections. The
DNA sequences of 13 K1 PCR positives (285 bp), 10
K2 PCR positive (352 bp) and 8 Wo PCR positives
Table 1. The number of koalas sampled in this study based on state of origin, sex and year
State of origin
Sex of koalas Year of sample collection
Male Female 2006 2007 2008 2009
n=326 n=269 n=53 n=111 n=90 n=341
QLd n=504 270 234 51 93 80 280
NSW n=91 56 35 2 18 10 61
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sequences for the respective trypanosome species.
Geography and trypanosome infection
The geographical distribution of koalas infected with
the three trypanosome species is presented in Fig. 2a,
b and c. Of the koalas sampled, 84% originated from
QLdandtheremainder(15·3%CI:12·5–18·4%) from
NSW. There was no signiﬁcant diﬀerence in the
proportion of males and females sampled from the
two states (P>0·05). There was a signiﬁcantly higher
prevalence of T. irwini infection (73·5% CI: 67·5–
79%) compared to T. gilletti (14·5% CI: 10·3–19·5%)
and T. copemani (3·7% CI: 1·7–6·9%) in koalas from
the Moreton Bay Regional Council Shire, which was
the origin of the highest number of koalas.
Month of sampling and trypanosome infection
The majority of samples were collected in 2009
(n=488; 18–78 koalas sampled/month). The
prevalence of trypanosome infection in koalas
sampled each month during 2009 is presented in
Fig. 3. The prevalence of T. irwini was highest in
June, August, September and October of 2009.
Trypanosoma gilletti and T. copemani infections
were more prevalent in koalas sampled in January,
August and September of 2009.
State of origin and trypanosome infection
The prevalence of T. irwini (P<0·001) and T. gilletti
(P<0·001) infection in koalas from NSW was
signiﬁcantly higher than in koalas from QLd. There
was no signiﬁcant diﬀerence in the prevalence of T.
copemani (P>0·05) infection in koalas from NSW
and QLd. Koalas from NSW were more likely to be
infected with T. irwini (OR: 3·4, 95% CI: 1·7–6·6)
and T. gilletti (OR: 2·0, 95% CI: 1·4–3·7) than koalas
from QLd. Koalas from NSW were more likely to be
infected with more than 1 trypanosome species (OR:
2·6, 95% CI: 1·6–4·1) than koalas from QLd.
Koala sex and trypanosome infection
Male koalas had a signiﬁcantly higher prevalence of
infection with T. gilletti (P<0·05) and T. copemani
(P<0·05) than female koalas. There was no signiﬁ-
cant diﬀerence in the prevalence of infection with
T. irwini in male and female koalas (P>0·05). Male
koalas were more likely than female koalas to be
infectedwithT.gilleti (OR:1·8,95%CI:1·2–2·7)and
T. copemani (OR: 3·6, 95% CI: 1·3–9·8).
The prevalence of infection with T. gilletti
(P<0·05) and T. copemani (P<0·05) were signiﬁ-
cantly higher in male koalas compared to female
koalas in QLd. Male koalas in QLd were more likely
than females to be infected with T. gilletti (OR: 1·7,
95% CI: 1·1–2·8) and T. copemani (OR: 4·1, 95% CI:
1·4–12·3).
123 4 5
SS2 fragment of 18S rDNA 959 bp
ab
T. copemani 457 bp
T. gilletti 373 bp
T. irwini 282 bp
Fig. 1. (a) Graphical representation of the size and position of PCR amplicons generated by the koala trypanosome-
speciﬁc nested PCRs for the ampliﬁcation of Trypanosoma copemani, T. gilletti and T. irwini from DNA extracted from
the blood of a koala infected with all 3 Trypanosoma spp. (b) An electrophoresis gel of the species-speciﬁc nested PCRs
performed on 1 koala. Lane 1, T. irwini-speciﬁc PCR; Lane 2, T. gilletti-speciﬁc PCR; Lane 3, T. copemani-speciﬁc
PCR; Lane 4, amalgamated negative controls for all 3 nested PCRs; Lane 5, 100bp DNA ladder.
Table 2. The composition of trypanosome
infections (percentage and 95% conﬁdence interval
(CI)) determined by PCR screening DNA extracted
from 595 koala blood samples using Trypanosoma
irwini, T. gilletti and T. copemani 18S rDNA
species-speciﬁc PCR primers
Trypanosoma spp.* Proportion positive (95% CI)
Ti−Tg−Tc− 26·2% (22·7–29·9%)
Ti+Tg−Tc− 50·3% (46·2–54·3%)
Ti+Tg+Tc− 17% (14–20·2%)
Ti+Tg+Tc+ 2·2% (1·2–3·7%)
Ti−Tg+Tc− 2·2% (1·2–3·7%)
Ti−Tg+Tc+ 0·2% (0·0–0·9%)
Ti−Tg−Tc+ 0·3% (0·2–0·9%)
Ti+Tg−Tc+ 1·7% (0·8–3·1%)
* Ti, T. irwini; Tg, T. gilletti; Tc, T. copemani.
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There was no signiﬁcant association between age and
theprevalenceofT.gilletti (P>0·05)andT.copemani
(P>0·05). The mean age of koalas infected with
T. irwini was signiﬁcantly higher (5·2±0·1 years)
compared to uninfected koalas (4·1±0·2 years)
(P<0·05).
Outcome of hospital admission and
trypanosome infection
Malekoalaswerefoundtobemorelikelythanfemales
(OR: 1·17, 95% CI: 1·0–1·4) to have a ‘non-survival’
outcome (P<0·05). A signiﬁcantly higher proportion
of koalas infected with T. gilletti did not survive
(P<0·05) compared to uninfected koalas. There was
Fig. 2. (a–d). The shires and number of koalas infected with Trypanosoma irwini (b, red), T. gilletti (c, blue) and
T. copemani (d, green) in NSW and QLd as determined by 18S rDNA species-speciﬁc PCRs. (a) Shires sampled (grey)
and location of the Australian Zoo Wildlife Hospital *. The proportions of PCR-positive koalas sampled in each shire
are represented.
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of koalas infected with T. irwini (P>0·05) and
T. copemani (P>0·05) compared to uninfected
koalas. Koalas with a ‘non-survival’ outcome were
more likely to be infected with T. gilletti than koalas
with a ‘survival’ outcome (OR: 1·6, 95% CI: 1·1–2·3).
A signiﬁcantly higher proportion of koalas with
mixed trypanosome infections were classiﬁed as
‘non-survival’ compared to uninfected koalas
(P<0·05). A signiﬁcantly higher proportion of koalas
from NSW that were infected with T. gilletti or a
mixed infection died or were euthanased (‘non-
survival’ outcome) compared to uninfected koalas
from NSW (P<0·05).
Body condition score and trypanosome infection
The mean body condition score for koalas infected
with T. gilletti (5·2±0·2) was signiﬁcantly lower than
the mean body condition score of uninfected koalas
(5·8±0·1) (P<0·05). The mean body condition score
of koalas co-infected with T. gilletti and T. irwini
(5·2±0·2) was signiﬁcantly lowerthanthe meanbody
condition score of uninfected koalas (5·7±0·1)
(P<0·05). There was no signiﬁcant diﬀerence in the
mean body condition scores of koalas infected with
T. irwini or T. copemani compared to uninfected
koalas (P>0·05).
Koala blood PCV and trypanosome infection
Koalas with signs of blood loss (215/595) were
excluded from the analysis of PCV. The mean PCV
of koalas without blood loss infected with T. gilletti
(29·87±0·7%) or T. copemani (27·56±1·83%) was
signiﬁcantly lower compared to uninfected koalas
without blood loss (32·27±0·3% and 31·95±0·28%
respecively) (P<0·05, with equal variances not
assumed). There was no signiﬁcant diﬀerence in the
mean PCV values of koalas without blood loss
infectedwith T. irwini compared to uninfectedkoalas
without blood loss (P>0·05).
The mean PCV value for koalas with ‘non-
survival’ outcomes that were infected with T. gilletti
(27·9±0·8%) was signiﬁcantly lower compared to
uninfected koalas (30·3±0·5%) with ‘non-survival’
outcomes (P<0·05). There was no signiﬁcant diﬀer-
ence between the mean PCV values of koalas with a
‘non-survival’ outcome and infection with T. cope-
mani and T. irwini compared to uninfected koalas
with a ‘non-survival’ outcome (P>0·05).
PCV values were signiﬁcantly lower in koalas from
NSW compared to QLd, in koalas which ‘appeared
sick’comparedtothosethat‘appearedhealthy’andin
koalas with ‘non-survival’ compared to koalas with
‘survival’ outcomes (P<0·05). There were no sig-
niﬁcant diﬀerences in PCV values of koalas with
respect to gender (P>0·05).
Other diseases/observations and trypanosome infection
A total of 48·4% (CI: 44·3–52·5%), 6·9% (CI: 5–9·2%)
and 5% (CI: 3·4–7·1%) of koalas were observed with
signs of chlamydiosis, kAIDS and bone marrow
disease respectively. There was no signiﬁcant associ-
ation between any speciﬁc disease and infection
with the 3 trypanosome species detected. There
were no signiﬁcant associations between any of the
Trypanosoma spp. infections and signs of trauma or
observations of koalas appearing sick (P>0·05).
The mean body condition score of koalas with
signs of chlamydiosis (5·0±0·1), bone marrow dis-
ease (3·9±0·3) and kAIDS (2·9±0·1) was sig-
niﬁcantly lower than the mean body condition
score of koalas with no clinical signs of chlamydiosis
Fig. 3. The percentage of koalas admitted to the Australian Zoo Wildlife Hospital, Beerwah, QLd, Australia that were
infected with Trypanosoma irwini, T. gilletti or T. copemani by month from the period January–December 2009 as
determined by 18S rDNA species-speciﬁc PCRs.
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(5·9±0·1) (P<0·001). There was no signiﬁcant
diﬀerence in PCV in koalas with (31·8±0·42%) and
without (33·1±0·65%) signs of chlamydiosis
(P>0·05).
Koalas with signs of ‘disease’ (kAIDS, chlamy-
diosis and BMD) had signiﬁcantly lower PCV values
(31·5±0·36%) compared with koalas without signs of
these diseases (33·1±0·65%) (P<0·05). A signiﬁ-
cantly higher proportion of koalas classiﬁed with
signs of these diseases had ‘non-survival’ outcomes
compared to ‘survival’ outcomes than those without
(OR: 4·6, 95% CI: 3·2–6·5) (P<0·001).
Comparison of trypanosome infection in koalas
with and without signs of chlamydiosis was con-
ducted with all koalas with signs of kAIDS and/or
BMD removed. No signiﬁcant diﬀerences in PCV
(except with T. copemani in koalas without chlamy-
diosis, BMD or kAIDS), outcome or BCS were
identiﬁed with T. irwini or T. copemani infection
in koalas with or without signs of chlamydiosis
(P>0·05). The only trypanosome with statistically
reduced PCV values in koalas without signs of
chlamydiosis, BMD or kAIDS was T. copemani
(n=6) (23·7±3·2%) (P<0·001). Statistically signiﬁ-
cantdiﬀerencesinPCVandBCSwereidentiﬁedwith
T. gilletti infection in koalas with signs of chlamy-
diosisbutnotinkoalaswithoutsignsofchlamydiosis.
The PCV of koalas with signs of chlamydiosis
and a T. gilletti infection was signiﬁcantly lower
(29·5±1·05%) compared to koalas that were not
infected with T. gilletti (32·4±0·44%) (P<0·05)
(Fig. 4a). The mean BCS of koalas with signs of
chlamydiosis with a T. gilletti infection was signiﬁ-
cantly lower(4·6±0·26) compared to koalasthat were
not infected with T. gilletti (5·4±0·14) (P<0·05)
(Fig. 4b). A higher but not statistically signiﬁcant
proportion of koalas with signs of chlamydiosis and a
T. gilletti infection had non-survival outcomes
(70·2%, 95% CI: 55·1–82·7%) compared to koalas
that were not concurrently infected with T. gilletti
(58·1%, 95% CI: 50·6–65·2%) (P>0·05) (Fig. 4c).
DISCUSSION
Species-speciﬁcPCRs weresuccessfully developedto
detect infection of 3 native Australian Trypanosoma
spp. identiﬁed in koalas. Only 3 Trypanosoma spp.
were detected in the koalas sampled in this study.
This observation was conﬁrmed by the absence of
ampliﬁcation in the species-speciﬁc PCR-negative
samples when they were tested using a nested
trypanosomatid 18S rDNA PCR (McInnes et al.
2011). This nested PCR was designed to amplify a
diverse range of trypanosomatids (McInnes et al.
2009, 2011). It is possible that other trypanosome
species were present at a level of parasitaemia below
thedetection thresholdofthisPCR.Itisalso possible
that the PCR failed to amplify other trypanosome
species due to the presence of PCR inhibitors or
primer speciﬁcity issues. This is diﬃcult to investi-
gategiven the scope of the current study. In addition,
all recently identiﬁed Australian species of trypano-
somes have been readily ampliﬁed using this PCR
(Austen et al. 2009; McInnes et al. 2009, 2011).
The prevalence of infection with T. irwini (71·1%)
in koalas in this study was considerably higher than
previous studies, which identiﬁed T. irwini infection
in38·2%to52%ofkoalas(McInnesetal.2009,2011).
These previous studies used datasets that are subsets
of this larger study and, therefore the results of this
study are likely to be more accurate because of the
largersamplesizethatcomprisedkoalassampledover
1 year. The diﬀerence is not likely to be due to
variation in the sensitivity of the trypanosomatid
PCR originally used and the species-speciﬁcP C R s
that were subsequently developed. There was 100%
agreement between the previous results and the
results from re-screening all samples from the ﬁrst
2 studies with the species-speciﬁcP C R s .
Fig. 4. (a) The percentage packed cell volume (PCV) (5% error bar), (b) mean body condition score (BCS) (±S.E.) and
(c) the percentage of koalas with a bad outcome (±S.E.) with (□) or without (▲) Trypanosoma gilletti infection. Koalas
were grouped as follows: H, healthy koalas with no sign of Chlamydia infection, koala AIDS and or bone marrow
disease; D, diseased koalas, those with signs of the previous mentioned diseases; and C, koalas with signs of Chlamydia
infection only.
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that had been previously tested and shown to contain
only T. irwini using species-speciﬁc PCRs is inter-
esting. This suggests that preferential PCR ampliﬁ-
cation of T. irwini may have occurred and masked
mixed trypanosome infections. This is an important
ﬁnding because the generation of a clean sequence
chromatogram is usually accepted as evidence of a
single infection. Mixed trypanosome infections were
common in koalas (21%). The predominant mixed
infection was a co-infection of T. irwini and T. gilletti
(17%), which includes almost all koalas infected
with T. gilletti. Interestingly, only 1 co-infection of
T. gilletti and T. copemani was identiﬁed in the study
despite the fact that many koalas originated from
shires in which both species of trypanosomes were
present. Trypanosomacopemani wasmore common as
a dual or triple co-infection with T. irwini than in
a dual infection with T. gilletti. This is, however,
most probably a reﬂection of the low prevalence of
T. copemani (4·4%) in the koala population.
To date, T. irwini and T. gilletti have only been
foundinkoalaswhilstT.copemani,ontheotherhand,
is known to occur in a range of Australian marsupials
(wombats, quokkas, Gilbert’s potoroo and koalas) in
diﬀerent regions of Australia (Noyes et al. 1999;
Hamilton et al. 2004; Austen et al. 2009; McInnes
et al. 2011). It istherefore possible that the koala is an
accidental host for T. copemani which may explain its
low prevalence (4·4%) in koalas and low prevalence
of co-infection with T. gilletti. It could also be due
to heterologous immunity resulting from a possible
antigenic similarity between T. gilletti and
T. copemani, which are genetically closely related
(McInnes et al. 2011), or due to non-speciﬁc
interactions of inﬂammation mediators (Cox, 2001).
Heterologous immunity is known to occur with a
range of malaria species (Voller et al. 1966; Maitland
et al. 1997) but has also been observed between
diﬀerent intra-erythrocytic protozoan genera
(Babesia and Plasmodium) (Cox, 1968; Cox and
Milar, 1968). An example of cross-protection with
trypanosomes was given by Uche and Jones (1994)
where rabbits, experimentally infected with T. evansi
and then challenged with heterologous trypanosome
species, had protection conferred to the most closely
related trypanosome T. brucei, but not to the more
distantly related trypanosomes, T. congolense and
T. vivax. Similarly, in mice, infection with T. rangeli
has been shown to provide protective immunity
against infection with a virulent T. cruzi strain
(Zuniga et al. 1997).
The diﬀerences observed in the geographical
distribution of trypanosome-infected koalas are
diﬃcult to interpret. The statistical comparison of
infection by state revealed signiﬁcant diﬀerences in
the prevalence of T. irwini and T. gilletti infection
with infection by both trypanosome species more
likely in koalas from NSW than QLd. There was,
however, a deﬁnite sampling bias present in this
study because QLd shires closest to the AZWH were
the source of the majority of hospital admissions and
distant shires, in particular, those in NSW were
represented by veryfewkoalas, and those thatneeded
more urgent veterinary attention. Therefore, statisti-
cal analysis of trypanosome infection at the level of
shire and state was inappropriate.
The ﬁnding that male koalas had a signiﬁcantly
higher prevalence of infection with T. gilletti and
T. copemani compared to females is interesting. The
observed diﬀerence was maintained when the state of
origin was included in the analysis. The diﬀerence is
not due to a sampling bias because there was no
signiﬁcant diﬀerence in the gender distribution in the
koalas sampled in the two states. The diﬀerence in
infection rates in males may be related to physiologi-
cal diﬀerences or social hierarchy and diﬀerential
activities of sexes. During the koala breeding season
(from July to December), dominant males become
active at dusk and move from tree to tree, scent
marking, checking the status of females and ﬁghting
with other males for access to oestrus females (Lee
and Carrick, 1989).
The observation that the mean age of koalas
infected with T. irwini is higher than uninfected
koalas is best explained by T. irwini manifesting as a
chronic and/or non-pathogenic infection, thereby
leading to an increasing prevalence with age. The
same pattern was not seen with T. copemani-infected
koalas, possibly due to the small sample size (n=26).
The prevalence of all three trypanosome species was
lower in juvenile (0 to 2-year-old) koalas followed by
an increase in the next age group (2 to 4-year-old
koalas). This suggests that koalas predominantly
become infected at 2–4 years of age, which coincides
with dispersal from the maternal home range and
sexual maturation. Female koalas begin to breed at
2–3 and males at 4–5 years of age (Lee and Carrick,
1989). This stage of a koala’s life leads to an increase
in social behaviour, movement and activity patterns.
This increase in physical activity is likely to increase
the risk of contact with haematophagous arthropods
such as ticks, a possible vector of native Australian
trypanosomes as inferred by the phylogenetic place-
ment of the tick-transmitted trypanosome isolate
KG1 (Thekisoe et al. 2007) with T. gilletti and
T. copemani (McInnes et al. 2011).
The diﬀerences in PCV values between T. gilletti
and T. copemani-infected koalas and uninfected
koalas, although statistically signiﬁcant, are not as
marked as those reported with infections with
the highly pathogenic African trypanosomes. Only
the mean PCV values of T. copemani (23·7±3·2%)
infected koalas (in koalas without signs of any other
disease) was lower than the referencerangeof 29–44%
(Canﬁeld et al. 1989b). The sample size of
T. copemani-infected koalas without signs of other
diseases was small (n=6) and in koalas with
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PCV associated with infection with T. copemani.I ti s
diﬃcult to interpret the results related to infection
with T. copemani further because of its low preva-
lence in this population. A signiﬁcant regenerative
anaemia was observed in a small number of koalas
that were infected with a trypanosome as evidenced
by the presence of abnormally increased numbers of
reticulocytes and nucleated erythrocytes (normo-
blasts) supported by hypercellular bone marrow
on prepared blood and bone marrow smears
(A. Gillett, personal communication). Anaemia is
commonly associated with human (Chisi et al. 2004)
and animal trypanosomiasis, reported in native
African cattle breeds (Ellis et al. 1987; Sekoni et al.
1990; Akinbamijo et al. 1998; Mahama et al. 2004),
horses (Silva et al. 1995), pigs (Omeke and Ugwu,
1991), sheep (Katunguka-Rwakishaya et al. 1992;
Onah et al. 1996), goats (Goossens et al. 1998;
Ogunsanmi and Taiwo, 2001;F a y eet al. 2005) and
dogs (Onyeyili and Anika, 1990; Egbe-Nwiyi and
Antia, 1993) and cats (Da Silva et al. 2009). Anaemia
is, however, not always noted with trypanosome
infections, in part due to the fact that numerous
trypanosomes are non-pathogenic and also due to the
variable disease dynamics of pathogenic trypano-
somes. Anaemia is also commonly detected in
diseased koalas, in particular those with complicated
cystitis and lymphosarcomas (Canﬁeld et al. 1989a).
The same authors observed that uncomplicated
cystitis or conjunctivitis and clinical symptoms of
chlamydiosis did not noticeably impact haematolo-
gical values. As the PCV value reductions in koalas
with trypanosome infection were not marked the
eﬀect may not be biologically signiﬁcant. Reduced
PCV levels in koalas have also been attributed to
heavy tick infestations (Obendorf, 1983; Spencer
and Canﬁeld, 1995) and details of the tick burden of
koalas in this study were infrequently recorded in
admission examinations.
The results of this study showed that koalas with
signs of other ‘diseases’ (chlamydiosis, BMD and/or
kAIDS) and infected with T. gilletti had signiﬁcantly
lower body scores than koalas not infected with
T. gilletti. Body condition score is a commonly used
measure to assess the general health of a koala
(Jackson et al. 2003). It is similar to other ranking
methodologies used to monitor and assess the health
of domesticated animals. Decreased body condition
scores have been observed in association with try-
panosome infection in a range of animals (Mutayoba
et al. 1995; Clausen et al. 2003; Singh et al. 2004;
Gonzales et al. 2007; Jimenez-Coello et al. 2008).
Similar to the reduced PCV value there was only a
statistically signiﬁcant reduction in BCS in koalas
thatwereinfectedwithT.gillettiandshowingclinical
signs of other ‘diseases’.
The initial analysis of health parameters PCV,
BCS and outcome indicated that T. gilletti infection
might be exerting a negative impact on the health of
koalas. Further analysis, however, revealed that these
eﬀects were only notable in koalas with signs
of other concurrent diseases (chlamydiosis, BMD
and/or kAIDS) and absent in koalas without these
disease syndromes. There is limited understand-
ing of concomitant infections as the interactions
involved are often complex and diﬃcult to unravel.
The reduction in health parameters with concomi-
tant infections which include a trypanosome may
be due to condition-dependent pathogenicity
or potentiation of concurrent infections resulting
from trypanosomiasis-induced immunosuppression.
Condition-dependent pathogenicity occurs when
normally benign infections become pathogenic in
hosts that are immunosuppressed or concurrently
infected with other pathogens. This concept has been
demonstrated in detail with the non-pathogenic
trypanosomatid Crithidia bombi, which infects bum-
blebees (Brown et al. 2003), and under conditions of
stress results in disease. It has also been suggested to
explain the phenomenon of clinical trypanosomiasis
in cattle infected with the non-pathogenic bovine
trypanosome T. theileri (Doherty et al. 1993; Seiﬁ,
1995; Ward et al. 1984). Trypanosomiasis-induced
immunosuppression which is the mechanism behind
trypanosome potentiation of concurrent infections
was ﬁrst observed in trypanosome-infected rats and
mice challenged with heterologous red blood cells
(Goodwin, 1970; Goodwin et al. 1972). Immuno-
suppression by trypanosomes renders hosts more
susceptible and potentiates other concurrent infec-
tions (Reid et al. 1979;G r i ﬃn et al. 1981; Khan and
Lacey, 1986; Kaufmann et al. 1992; Dwinger et al.
1994; Goossens et al. 1997; Onah et al. 2004; Carrera
et al. 2009) as well as reducing the capacity of hosts
torespondtoimmunizations(Fakaeetal.1999;Onah
and Wakelin, 2000). Trypanosome infections have
been reported to reduce antibody production of a
range of vaccinations for a range of disease agents
including Bacillus anthracis (Mwangi et al. 1990),
Brucella abortus (Rurangirwa et al. 1983), foot and
mouth disease (Sharpe et al. 1982), haemorrhagic
septicaemia (Singla et al. 2010) and swine fever
(Holland et al. 2003).
Analysis of outcome and trypanosome infection
was conducted in koalas without signs of BMD or
kAIDS syndromes as koalas with those diseases are
euthanased and their inclusion in the analysis of
outcome would have introduced unwanted bias into
the study. The observed higher (but not statistically
signiﬁcant) percentage of ‘non-survival’ outcomes
in koalas with signs of chlamydiosis and concurrent
T.gillettiinfectionscomparedtokoalasuninfectedby
T. gilletti may reﬂect the generally non-pathogenic
nature of trypanosomes of Australian native animals.
However, the ﬁnding that koalas that were infected
with T. gilletti and showing signs of concomitant
infections had signiﬁcantly lower BCS and PCV
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interaction occurring that may be adversely aﬀecting
the health of the koalas. Therefore, it is possible
that with a larger sample size the percentage of ‘non-
survival’ koalas with T. gilletti infection would
remain high and prove to be statistically signiﬁcant.
Further investigation is required to understand
the role of trypanosomes in the pathogenesis of
anaemia and other clinical syndromes in koalas,
particularly in view of the high prevalence of
potentially immune-modulating agents such as the
koalaretrovirus(Tarlintonetal.2008).Theimpactof
T. gilletti is complicated by endemic koala retrovirus,
which has features consistent with immunosuppres-
sion or immunodeﬁciency (Hanger et al. 2003),
similar to that observed with trypanosomiasis in
some hosts. Furthermore, there is a need to develop
new tools for assessing the immune status of koalas
because of the complicated nature of the outcome of
inter-current infections on the immune system of the
host.
This study has revealed that koala trypanosomes,
in particular T. gilletti, may have condition-
dependent pathogenic eﬀects on the ability to
potentiate concomitant infections. The negative
eﬀects on PCV values, body condition and survival
(not statistical), although not dramatic, provide
evidence that some of the trypanosomes infecting
koalas may not be entirely benign. Future research
of these trypanosomes and their interactions with
other koala diseases is imperative as trypanosomes
may be compromising the health of wild koalas and
contributing to koala population decline.
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